These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33034134)

  • 1. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
    Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
    Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
    Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
    Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
    Zhang Y; Zhu S; Yi L; Liu Y; Cui H
    Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
    Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
    Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Kim JT; Weiss HL; Evers BM
    Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
    Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
    Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
    Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
    Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
    Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
    Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
    Wang JG; Li NN; Li HN; Cui L; Wang P
    Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.
    Akter H; Yoon JH; Yoo YS; Kang MJ
    Mol Cells; 2018 Jun; 41(6):591-602. PubMed ID: 29794962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.
    Olszewski U; Hamilton G
    Mol Oncol; 2009 Jun; 3(3):204-13. PubMed ID: 19393580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.
    Dupouy S; Mourra N; Doan VK; Gompel A; Alifano M; Forgez P
    Biochimie; 2011 Sep; 93(9):1369-78. PubMed ID: 21605619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.